Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-12-17
1995-05-30
Mars, Howard T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514174, 514175, 514176, 540 2, 540 67, 540108, 540111, 540115, 540116, 540118, 540120, A61K 3158, C07J 3100, C07J 4300, C07J 3300
Patent
active
054201209
ABSTRACT:
Topically administrable C-21 thioether glucocorticoid steroid derivatives are disclosed as effective anti-inflammatory agents for the treatment of ophthalmic inflammatory disorders. These C-21 thioether derivatives do not cause a significant increase in intraocular pressure as a side effect.
REFERENCES:
patent: 3007923 (1961-11-01), Muller et al.
patent: 3687942 (1972-08-01), Anner
patent: 3803133 (1974-04-01), Vogt
patent: 3959260 (1976-05-01), Phillipps et al.
patent: 4427671 (1984-01-01), Torossian et al.
patent: 4472392 (1984-09-01), Anderson et al.
patent: 4472393 (1984-09-01), Shapiro
patent: 4477445 (1984-10-01), Philibert et al.
patent: 4524134 (1985-06-01), Kominek et al.
patent: 4588530 (1986-05-01), Lee
patent: 4617299 (1986-10-01), Knepper
patent: 4686214 (1987-08-01), Boltralik
patent: 4762919 (1988-08-01), Lee
patent: 4861765 (1989-08-01), Mitsukuhi et al.
patent: 4913852 (1990-04-01), Milioni et al.
patent: 5021408 (1991-06-01), Aubard et al.
patent: 5116829 (1992-05-01), Hori et al.
patent: 5202316 (1993-04-01), Claussner et al.
patent: 5215979 (1993-06-01), Andersson et al.
patent: 5223493 (1993-06-01), Boltralik
Carroll, F. I., J. of Heterocyclic Chemistry, 5(6), Dec. 1968. pp. 805-811.
Boltralik et al., "In Vivo and in Vitro Hydrolysis of Ophthalmic Steroids Using Rabbit Eyes," Invest. Ophthal., 13 (Supp.):78(1974), abstract.
Eilon et al., "Clinical Evaluation of Clobetasone Butyrate Eye Drops in the Treatment of Anterior Uveitis and its Effect on Intraocular Pressure," Br. J. Ophthal., 65:644-647 (1981).
Dunne et al., "Double-blind Clinical Trial of Topical Steroids in Anterior Uveitis," Br. J. Ophthal., 63:762-767 (1979).
Lloyd-Jones et al., "Clinical evaluation of clobetasone butyrate eye drops in episcleritis," Br. J. Ophthal., 65:641-643 (1981).
Lopez et al., "Dexamethasone 21-(.beta.-Isothiocyanatoethyl) Thioether: A New Affinity Label for Glucocorticoid Receptors," J. Med. Chem. 34:1762-1767 (1991).
Lusky et al., "Androstene-17-thioketals," Arzneim. Forsch/Drug Res. 36:1787-1795 (1986).
Milioni et al., "Pharmacological Study in vivo of the New Topical Anti-Inflammatory Steroid 21-Thiol-9.alpha.-fluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-3,2 0-dione-21-acetylamino Cysteine," Arznelm.Forsch/Drug Res. 41(11):741-743 (1991).
Mitsukuchi et al., "Studies on Topical Antiinflammatory Agents, V. 17-(Alkylthio)- and Methoxyalkanoates of Corticosteroids," Chem. Pharm. Bull. 38(3):692-697 (1990).
Mitsukuchi et al., "Studies on Topical Antiinflammatory Agents. III. Synthesis of 17.alpha.-Acyloxy-9.alpha.-fluoro-11.beta.-hydroxy-16.beta.-methyl-1,4-pre gnadiene-3,20-dione 21-Thio Derivatives and Related Compounds," Chem. Pharm. Bull. 37(12):3286-3293 (1989).
Philips et al., "Eye Drops of RU 486-6, A Peripheral Steroid Blocker, Lower Intraocular Pressure in Rabbits." The Lancet, vol. 1, No. 8380 (1984).
Ramsell et al., "Clinical Evaluation of Clobetasone Butyrate: a comparative study of its effects in postoperative inflammation and on intraocular pressure." Br. J. Ophthal. 64:43-45 (1980).
Simons, Jr., et al., "Synthesis and Biological Activity of Some Novel Chemically Reactive Glucocorticoids," J. Steroid Biochemistry 13:311-322 (1980).
Simons, Jr., et al., ".alpha.-Keto Mesylate: A Reactive, Thiol-Specific Functional Group," J. Org. Chem. 45:3084-3088 (1980).
Simons, Jr., et al., "Fluorescent Chemoaffinity Labeling, Potential Application of a New Affinity Labeling Technique to Glucocorticoid Receptors," Biochemistry 18(22):4915-4922 (1979).
Southren et al., "Intraocular Hypotensive Effect of a Topically Applied Cortisol Metabolite: 3.alpha., 5.beta.-Tetrahydrocortisol." Investigative Ophthalmology & Visual Science, 28:901-903 (1987).
Williamson et al., "Clobetasone Butyrate Eye Drops: Effect on Ocular Inflammation and Intraocular Pressure." Trans. Ophthal. Soc. U.K., 101:27-29 (1981).
Wojnar et al., "Androstene-17-thioketals," Arzneim-Forsch./Drug Res. 36(11):1782-1787 (1986).
Mitsukuchi et al., "Studies on Topical Antinflammatory Agents. IV. 21-(Alkylthio)acetates and (Methylthio)meth-oxides of Corticosteroids," Chem. Pharm. Bull. 38(3):786-789 (1990).
Alcon Laboratories Inc.
Kestler Kimberly J.
Mars Howard T.
Ryan Patrick M.
LandOfFree
Anti-inflammatory glucocorticoid compounds for topical ophthalmi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory glucocorticoid compounds for topical ophthalmi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory glucocorticoid compounds for topical ophthalmi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-361911